Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-31 07:53 |
Pharming Group provides update on ongoing regulatory review of leniolisib for t…
|
English | 239.4 KB | ||
| 2024-05-22 08:26 |
Pharming Group reports on results of the 2024 Annual General Meeting of Shareho…
|
Dutch | 178.7 KB | ||
| 2024-05-22 08:26 |
Pharming Group reports on results of the 2024 Annual General Meeting of Shareho…
|
English | 174.1 KB | ||
| 2024-05-15 08:46 |
Pharming Group announces the early redemption of the remaining outstanding €125…
|
Dutch | 206.9 KB | ||
| 2024-05-15 08:46 |
Pharming Group announces the early redemption of the remaining outstanding €125…
|
English | 204.1 KB | ||
| 2024-05-08 08:35 |
Pharming Group reports first quarter 2024 financial results and provides busine…
|
Dutch | 539.9 KB | ||
| 2024-05-08 08:35 |
Pharming Group reports first quarter 2024 financial results and provides busine…
|
English | 523.1 KB | ||
| 2024-05-02 16:01 | English | 37.5 MB | |||
| 2024-04-24 09:15 |
Pharming to be honored as Industry Innovator at National Organization for Rare …
|
Dutch | 266.3 KB | ||
| 2024-04-24 09:15 |
Pharming to be honored as Industry Innovator at National Organization for Rare …
|
English | 275.9 KB | ||
| 2024-04-24 08:07 |
Pharming Group to report first quarter 2024 financial results on May 8
|
Dutch | 210.3 KB | ||
| 2024-04-24 08:07 |
Pharming Group to report first quarter 2024 financial results on May 8
|
English | 207.9 KB | ||
| 2024-04-22 07:43 |
Pharming Group announces the repurchase of outstanding €125 million convertible…
|
Dutch | 271.6 KB | ||
| 2024-04-22 07:43 |
Pharming Group announces the repurchase of outstanding €125 million convertible…
|
English | 272.7 KB | ||
| 2024-04-19 07:42 |
Pharming Group announces the placement of €100 million convertible bonds due 20…
|
Dutch | 283.8 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
